
NLTX
Healthcare · Biotechnology · $8.2M market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2023
EPS trend, 90 days to now · +100.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 14, 2023 | Before the open | -0.10 | -0.41 | -331.6% |
| Aug 10, 2023 | After the close | -0.04 | -0.04 | 0.0% |
| May 8, 2023 | After the close | -0.12 | -0.26 | -116.7% |
| Mar 20, 2023 | After the close | -0.19 | -0.24 | -26.3% |
| Nov 14, 2022 | After the close | -0.30 | -0.24 | +20.0% |
| Aug 9, 2022 | After the close | -0.30 | -0.28 | +6.7% |
| May 9, 2022 | After the close | -0.30 | -0.28 | +6.7% |
| Mar 1, 2022 | After the close | -0.30 | -0.28 | +6.7% |
| Nov 4, 2021 | After the close | -0.28 | -0.28 | 0.0% |
| Aug 5, 2021 | After the close | -0.26 | -0.27 | -3.8% |
| May 12, 2021 | Before the open | -0.23 | -0.27 | -17.4% |
| Mar 25, 2021 | After the close | -0.25 | -0.24 | +4.0% |
| Nov 9, 2020 | Before the open | -0.22 | -0.19 |
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The…
| +13.6% |
| Aug 12, 2020 | After the close | -0.21 | -0.20 | +4.8% |
| May 6, 2020 | After the close | -0.24 | -0.18 | +25.0% |
| Mar 12, 2020 | After the close | -0.37 | -0.22 | +40.5% |
| Nov 13, 2019 | Before the open | -0.04 | -0.44 | -1000.0% |
| Aug 1, 2019 | Before the open | -0.05 | -0.09 | -80.0% |
| May 7, 2019 | Before the open | -0.23 | -0.09 | +60.9% |
| Mar 7, 2019 | Before the open | -0.79 | -0.21 | +73.4% |
| Nov 7, 2018 | Before the open | -0.21 | -0.64 | -204.8% |
| Aug 8, 2018 | Before the open | -0.12 | 0.12 | +200.0% |
| May 8, 2018 | Before the open | -0.66 | -0.62 | +6.1% |
| Mar 12, 2018 | After the close | -0.57 | -0.69 | -21.1% |